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Caffeine is one of the world’s most consumed substances. It is present in coffee, green tea and guarana, 
among others. The xenobiotic-sensing nuclear receptor subfamily 1, group I, member 3 (Nr1i3), also 
known as the Constitutive Androstane Receptor (Car) is a key regulator of drug metabolism and excretion. 
No consistent description of caffeine effects on this receptor has been described. Thus, to unravel the 
effects of caffeine on this receptor, we performed experiments in mice. First, C57Bl/6 mice that were 
treated daily with caffeine (50 mg/kg) for 15 days presented a slight but significant increase in Nr1i3 
and Cyp2b10 gene expression. A second experiment was then performed to verify the effects of caffeine 
on TCPOBOP (1,4-bis-[2-(3,5-dichloropyridyloxy)]benzene, 3,3′,5,5′-tetrachloro-1,4-bis(pyridyloxy)
benzene), the most potent agonist known for mice Nr1i3. Interestingly, caffeine potentiated TCPOBOP 
pleiotropic effects in mice liver, such as hepatomegaly, hepatotoxicity, hepatocyte proliferation and loss 
of cell-to-cell communication through gap junctions. In addition, caffeine plus TCPOBOP treatment 
increased liver gene expression of Nr1i3 and Cyp2b10 comparing with only caffeine or TCPOBOP 
treatments. Together, these results indicate that caffeine increases the expression of Nr1i3 in mice liver, 
although at this point it is not possible to determine if Nr1i3 directly or indirectly mediates this effect.
Uniterms: Caffeine/effects/experimental study. Androstane constitutive receptor/caffeine effects. 
1,4-bis-[2-(3,5-dichloropyridiloxy)]benzeno,3,3′,5,5-tetracloro-1,4-bis(pyridiloxy)benzene/caffeine 
effects. Cytochrome p450.
A cafeína é uma das substâncias mais consumidas mundialmente, estando presente no café, chá-verde 
e guaraná, entre outros. O receptor sensor de xenobióticos Receptor Nuclear subfamília 1, grupo I, 
membro 3 (Nr1i3, mais conhecido como Androstano Consititutivo - Car) é um regulador chave da 
biotransformação e excreção de substâncias e nenhuma descrição consistente dos efeitos da cafeína 
sobre este receptor foi feita. Então, para avaliar os efeitos da cafeína sobre este receptor, realizamos 
experimentos em camundongos. Primeiramente, camundongos C57/Bl/6 foram tratados diariamente 
com cafeína (50 mg/kg) por 15 dias e apresentaram um leve, mas significativo, aumento na expressão 
do Car e do seu gene alvo Cyp2b10. Assim, um segundo experimento foi realizado para verificar os 
efeitos da cafeína sobre o TCPOBOP (1,4-bis-[2-(3,5-dicloropiridiloxi)]benzeno,3,3′,5,5′-tetracloro-1,4-
bis(piridiloxi)benzeno), o mais potente agonista do Nr1i3 de camundongos conhecido. Interessantemente, 
a cafeína potencializou os efeitos pleiotrópicos do TCPOBOP no fígado dos camundongos, como 
hepatomegalia, hepatotoxicidade, proliferação celular e perda da comunicação intercelular por junções 
do tipo gap. Os camundongos tratados com cafeína e TCPOBOP apresentaram maior expressão gênica 
de Nr1i3 e Cyp2b10, quando comparados aos camundongos tratados apenas com cafeína ou TCPOBOP. 
Juntos, nossos resultados indicam que a cafeína aumenta a expressão do receptor CAR em fígados de 
camundongos C57/Bl/6, porém nesta etapa ainda não é possível afirmar se estes efeitos são direta ou 
indiretamente mediados pelo Nr1i3.
Unitermos: Cafeína/efeitos/estudo experimental. Receptor constitutivo de androstano/efeitos da cafeína. 
1,4-bis-[2-(3,5-dicloropiridiloxi)]benzeno,3,3,5,5-tetracloro-1,4-bis(piridiloxi)benzeno/efeito da cafeína. 
Citocromo p450.
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INTRODUCTION
Caffeine is one of the most consumed substances 
in the world, being present in coffee (Coffea sp.), green 
tea (Camelia sinensis), guaraná (Paullinia cupana) and 
also in pharmaceutical formulations (i.e. associated with 
acetaminophen as in Tylenol®) and soft drinks (Mandel, 
2002; Fukumasu et al., 2006). This xanthine alkaloid 
is best known for its psychoactive stimulatory effects 
as a consequence of competitive antagonism for the 
adenosine receptor (Fisone, Borgkvist, Usiello, 2004). 
After ingestion, caffeine is readily absorbed by the 
gastrointestinal system, distributed throughout the entire 
body and quickly metabolized, mostly by the liver, in 
three different metabolites: paraxanthine, theobromine and 
theophylline (Lelo et al., 1986). This biotransformation is 
catalyzed mostly by CYP1A2; however, other cytochrome 
p450 enzymes are involved, as CYP3A11 and CYP2C9 
(Kot, Daniel, 2007). As expected, caffeine treatment 
induces CYP1A2 expression in liver (Chen et al., 1996; 
Goasduff et al., 1996) but there is no evidence about the 
mechanism by which this enzyme expression is increased. 
Aryl-Hydrocarbon Receptor (AHR) is one of the receptors 
that regulate CYP1A family expression by binding of its 
specific ligands (Ma, Lu, 2007). Nonetheless, attempts 
failed to demonstrate that caffeine-induced CYP1A 
expression is due to AHR activation (Ayalogu et al., 1995).
Xenobiotic-sensing nuclear receptors such as AHR, 
the Nuclear Receptor subfamily 1, Group I, member 
3 (NR1I3, also known as the Constitutive Androstane 
Receptor) and the Nuclear Receptor subfamily 1, Group 
I, member 2 (NR1I2, also known as the Pregnane-X 
Receptor), have been identified as key regulators in 
drug metabolism. The mechanism of action behind 
these effects is the tight transcriptional regulation of 
several phase I and II drug-metabolizing genes (such 
as CYP2B, CYP3A, UGT1A1 and GSTA1), as well 
as drug transporter genes including Mrp2 and Oatp4 
(Willson, Kliewer, 2002). Accordingly, NR1I3 has been 
implicated in the metabolism of several xenobiotics 
(Wei et al., 2000; Zhang et al., 2002; Xie et al., 2003) as 
well as endobiotics ((Xie et al., 2003; Guo et al., 2003; 
Maglich et al., 2004; Saini et al., 2004). The pesticide 
contaminant 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene 
(TCPOBOP) is generally considered the most potent 
mouse Nr1i3 ligand known (Poland et al., 1980). In 
addition, TCPOBOP administration to mice induces 
the expression of Cyp2b10 through Nr1i3 activation 
(Tzameli et al., 2000). We previously showed that a 
single administration of TCPOBOP to mice induced 
hepatomegaly doubling liver weight at 72 h (Fukumasu et 
al., 2010). This effect mainly occurred due to increased cell 
proliferation (hyperplasia) over hepatocyte hypertrophy 
after TCPOBOP administration (Fukumasu et al., 2010; 
Bugyik et al., 2012). In addition, TCPOBOP transiently 
disrupted intercellular communication by GAP junctions 
in mouse liver (Fukumasu et al., 2010).
Therefore, we show here that oral (gavage) 
administration of caffeine to mice for 15 days altered 
Nr1i3 and Cyp2B10 gene expression in liver. We also 
further characterized the effects of caffeine administration 
along with TCPOBOP, since this substance is known as 
the most potent mouse Nr1i3 ligand.
MATERIAL AND METHODS
Chemicals
Caffeine was obtained from Labsynth (purity 
of >98.5%; São Paulo, SP, Brazil). TCPOBOP was 
synthesized as previously described (Dagli et al., 2004) 
and was kindly provided by Mrs. Croizy (Paris, France). 
Corn oil was Mazola® (São Paulo, Brazil). Alanine-
aminotransferase reagent kit was purchased from CELM 
(São Paulo, Brazil). The 3´3-diaminobenzidine (DAB), 
Trizma, Lucifer yellow, rhodamine, formalin, eosin, 
hematoxylin, and horseradish peroxidase anti-mouse IgG 
antibodies were obtained from Sigma Chemical Co. (Saint 
Louis, MO, USA). The Proliferating Cell Nuclear Antigen 
(PCNA) antibody, skimmed milk and LSAB were from 
Dako (Glostrup, Denmark). TRIzol, oligoDT primers, 
superscript II enzyme and Platinum SYBR Green were 
obtained from Invitrogen (Carlsbad, CA, USA). Assay-
on-Demand Gene Expression CAR (Mm004986_m1) 
and 18s (4319413E) and Taqman Mastermix were from 
Applied Biosystems (Foster City, CA, USA). Primers 
for Cyp2b10 and 18s were made by IDT technologies 
(Coralville, IA, USA). 
Animal experiments
Three-month-old female C57Bl/6 mice were bred 
at the animal facility of the Department of Pathology at 
the School of Veterinary Medicine and Animal Science 
of the University of São Paulo, Brazil, on a 12-hour 
light/12-hour dark cycle under controlled temperature 
conditions (20 ± 4 °C), and relative humidity (55 ± 10%). 
One replicate of experiment I was also performed at the 
Animal Facility of the Department of Basic Sciences 
at the School of Animal Science and Food Engineering 
of the University of São Paulo. Conditions at both 
animal facilities were the same. Mice had ad libitum 
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access to a standard diet (NUVILAB-CR1®, Nuvital 
Nutrientes LTDA, São Paulo, Brazil) and filtered water. 
All procedures using animals were performed following 
“Principles of Laboratory Animal Care” (NIH publication 
No. 85-23, revised in 1985) and were reviewed and 
approved by the Bioethics Committee of the SVMAS-USP 
(process number 953/2006).
The first experiment was performed with 10 females 
sorted randomly into two groups named CT (for control 
group) and CAF (for caffeine-treated). Caffeine (50 mg/kg) 
was diluted in filtered water and administered by gavage 
once a day for 15 days, while the control group received 
only filtered water (Figure 1). All animals were weighed 
every three days during the experiment and were quickly 
euthanized by deep anesthesia (thiopental 250 mg/kg, 
I.P., Thipentax® São Paulo, Brazil). Blood was collected 
from the heart for serum chemistry and livers were 
harvested, weighed and sampled for histological analysis 
or snap frozen in liquid nitrogen and conserved at -80 ºC 
until further analysis. The caffeine dose employed here 
(50 mg/kg) was considered safe for mice and used 
previously in other experiments (Chan et al., 2006). No 
intention to extrapolate this concentration to humans was 
considered in this experimental work.
The second experiment (Figure 1) was exactly as 
described above using 62 animals randomly sorted into 
two groups: CT (for control group) and CAF (for caffeine 
group). After 15 days of caffeine treatment by gavage, 
all animals were administered water, corn oil (vehicle) 
or a single dose of TCPOBOP (6 mg/kg) diluted in corn 
oil through gavage. They were maintained on caffeine or 
water treatment until euthanasia for 24, 48 and 72 h (2-3 
animals per treatment and time point), following the same 
procedures described for experiment 1 and published 
previously by our group (Fukumasu et al., 2010).
Histopathology and serum ALT analysis
Representative slices from each liver lobe were fixed 
in 10% formalin for 48 hours, dehydrated, processed, 
embedded in paraffin wax and stained with Hematoxylin 
and Eosin. Other major organs were also collected for 
analysis. Biochemical analysis of alanine-aminotransferase 
was performed accordingly to manufacturer’s instructions 
(CELM, São Paulo, Brazil).
Gene expression analysis by Real-time PCR
Total RNA was isolated from frozen liver tissues with 
TRIzol reagent following the manufacturer’s instructions 
(Invitrogen, Carlsbad, CA, USA). Then, photometrical 
FIGURE 1 - Experimental design. (A) Experiment I that 
evaluated the effects of caffeine on C57BL/6 female mice for 
15 days. (B) Experiment II where caffeine was evaluated in a 
model of Nr1i3 induction by the ligand TCPOBOP.
quantification was performed (Biophotometer, Eppendorf, 
Germany) for the 260/280 ratio. Only samples which 
had 1.7-2.0 and presented good quality after RNA 
electrophoresis in agarose gel (1.5%, TAE) were used. 
One µg of total RNA from each sample was treated with 
DNAse I and reverse transcribed with oligoDT primers 
and superscript II into cDNA. The cDNAs samples were 
used for real-timePCR carried out in an ABI Prism 7000 
thermocycler (Applied Biosystems, Foster City, CA, USA). 
For Nr1i3 analysis, Taqman Assay-on-Demand Gene 
Expression Products (Applied Biosystems) were used as 
follows: Nr1i3 (Mm004986_m1) and 18s (4319413E). 
For Cyp2b10 gene expression the SYBR-green method 
was used (Platinum SYBR Green, Invitrogen), using the 
18s ribosomal gene as the endogenous control. Primers 
were designed (IDT technologies, Coralville, IA, USA) 
with Primer-3 software (Rozen and Skaletsky, 2000) 
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and were run in BLAST (Altschul et al., 1990) to verify 
the absence of local alignments with DNA and other 
RNA transcript sequences. The following primers were 
used: Cyp2b10_F: CCTGTGGTTATGCTGTGTGG, 
Cyp2b10_R: CCACTAAACATTGGG CTTCC, product 
size 244bp; 18s_F: CCTGCGGCTTAATTTGACTC, 
18s_R: CTGTCAATCCTGTCCGTGTC, product size 
45bp). Finally, analysis of relative gene expression data 
was performed according to the 2^[ -delta delta Ct ] 
method (Livak, Schmittgen, 2001).
Immunohistochemistry for the proliferation cell 
nuclear antigen (PCNA)
Detection of the Proliferating Cell Nuclear Antigen 
(PCNA, PC 10, diluted 1:3200) was performed in 
representative liver sections (5 μm) from animals from 
experiment 2 as previously described (Fukumasu et al., 
2010). Positive PCNA cells have their nucleus colored 
brown due to DAB deposition; and at least 1000 cells were 
counted per animal. The proliferation index was obtained 
by dividing the number of brown nuclear stained cells 
by the total number of cells counted for each animal and 
multiplied per 100. Binucleated cells were not considered 
for this analysis. PCNA is detected in G1, S and G2 
cell cycle phases (Foley et al., 1993), which were all 
considered in this study with no distinction.
Gap Junction Intercellular Communication (GJIC) 
analysis
Incision Loading Dye Transfer was performed (Sai 
et al., 2000) with minor modifications (Fukumasu et al., 
2010). Areas stained with LY alone or with RhD were 
detected by fluorescence emission using a microscope 
(Nikon Eclipse-800, Japan) equipped with an epi-
fluorescence unit. The net area stained with LY alone and 
the length of incision was quantified with an electronic 
pen and the software calculated automatically (Image 
Pro-Plus, version 4.5, Media Cybernetics). At least three 
of the incision sites per specimen were randomly chosen 
for analysis and the mean value was used as the data from 
one animal. The distance of dye transfer from the incision 
line (area/length) was represented as GJIC and values were 
expressed as a fraction of the control value.
Statistical analysis
Data are presented as mean ± standard deviation. 
Two-way ANOVA was used for comparisons where 
two measures were evaluated: body weight and gene 
expression through time. Bonferroni post-test was used 
after two-way ANOVA. All other statistical analyses were 
performed with Mann-Whitney non-parametric test. The 
software Prism 5 for windows® (GraphPad Software, Inc, 
USA) was used for all statistical analyses.
RESULTS
Experiment 1
Daily treatment with 50 mg/kg of caffeine for 
15 days to female C57Bl/6 mice had no effect on body 
weight, liver weight and serum ALT (data not shown). 
Also, no alterations were observed in necropsies or 
histopathological analysis of organs such as liver, kidneys, 
stomach, spleen and lungs (data not shown).
We found an increased expression of Nr1i3 (p=0.04, 
Figure 2) after caffeine treatment. To confirm this finding, 
we evaluated the level of Nr1i3 specific target Cyp2b10. 
Interestingly, Cyp2b10 (p= 0.009, Figure 2) presented a 
significant increment in gene expression after caffeine 
treatment. Noteworthy was the fact that sole administration 
of caffeine for 15 days to mice presented no major effect 
as weight loss or hepatotoxicity but increased Nr1i3 gene 
expression and Nr1i3 transcriptional function, since 
increased levels of Cyp2b10 mRNA was demonstrated.
Experiment 2
We performed the second experiment to verify if 
caffeine presented an additive effect with the most potent 
ligand for Nr1i3 in liver, TCPOBOP. After TCPOBOP 
administration to control and caffeine-treated mice, a 
significant decrease in body weight was noted in caffeine-
treated animals over time (p=0.0027 for treatment, 
p=0.2917 for time; two way ANOVA, Figure 3). The 
administration of vehicle (corn-oil) to control- or caffeine-
treated mice had no effect or interaction of vehicle with 
FIGURE 2 - Effects of caffeine in gene expression of Nr1i3 and 
Cyp2b10. * means P<0.05 between CT and CAF groups; ** 
P<0.01 between CT and CAF groups.
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caffeine on body weight or liver weight (Figure 3). 
However, caffeine potentiated the effects of TCPOBOP 
in mice as the TCPOBOP-induced hepatomegaly after 
48 h and 72 h (p<0.001 for treatment and time; with a 
significant interaction of p=0.0007; two way ANOVA, 
Figure 3) and the TCPOBOP-induced hepatotoxicity after 
72 h showed by increased ALT levels in caffeine treated 
animals (p<0.01, Figure 3). Therefore, since all the effects 
FIGURE 3 – Results from experiment II. (A) Body weight of CT 
or CAF-treated animals for 15 days and then administered by 
gavage water, corn-oil (vehicle for TCPOBOP) or TCPOBOP. 
(B) Relative liver weight of CT and CAF-treated mice after 
TCPOBOP administration (time 0h – day 15). (C) Alanine 
aminotransferase in sera of CT and CAF treated mice after 
TCPOBOP administration. * <0.05 and **<p.001.
were seen 48 or 72 h after TCPOBOP administration, we 
chose to evaluate the cellular and molecular effects of 
caffeine plus TCPOBOP at 24 h to determine the priming 
effect of caffeine on TCPOBOP pleiotropic effects.
Twenty-four hours after TCPOBOP administration, 
caffeine potentiated the TCPOBOP effects shown by 
increased liver cell hyperplasia (p=0.0273; Fig. 4) and 
altered cell-to-cell communication by gap junctions 
(p<0.05, Fig. 4). We also checked if caffeine could have 
any effects on TCPOBOP-induced gene expression of 
Nr1i3 and Cyp2b10. First we showed that TCPOBOP 
increased Nr1i3 and Cyp2b10 gene expression after 24 h of 
administration (CAR: 1.29 fold, p=0.0374 and Cyp2B10: 
54.1 fold, p<0.0001; Figure 4) as did caffeine (Figure 2). 
Twenty-four hours after TCPOBOP administration, 
caffeine pre-treatment potentiated the Nr1i3 and Cyp2b10 
gene expression after 24 h of TCPOBOP administration 
by 46% (p=0.0055) and 94% (p=0.0444), respectively, 
in comparison with TCPOBOP-only treated animals 
at this time point. Hence, in this second experiment 
we demonstrated that caffeine potentiated the effects 
of TCPOBOP in mice liver as shown by macroscopic, 
microscopic and molecular analysis.
DISCUSSION
In this study, we showed that oral administration 
of 50 mg/kg of caffeine for 15 days to mice increased 
gene expression of Nr1i3 and one of its transcriptional 
targets (Cyp2b10) in the liver. Also, we demonstrated 
that caffeine potentiated the pleiotropic effects of 
TCPOBOP in mice liver, a substance known as the most 
potent mouse Nr1i3 ligand (Poland et al., 1980). These 
experiments demonstrated that caffeine administration to 
C57/Bl female mice altered the Nr1i3 function in the liver; 
however, at this point we are not able to affirm if this effect 
is direct to Nr1i3 or indirect.
Caffeine, one of the world’s most consumed 
substances, deserves attention regarding its effects on 
xenobiotic nuclear receptors due to their importance in 
drug metabolism and biotransformation. As an example, 
Nr1i3 was shown to play a key role in acetaminophen 
(APAP) metabolism and hepatotoxicity (Zhang et al., 
2002). It is known that APAP toxicity is by far the most 
common cause of acute liver failure in United States 
(Larson et al., 2005). The combination of APAP and 
caffeine is used worldwide to treat pain from several 
conditions such as headaches, colds, fever and others 
in several commercially available formulations. It has 
long been demonstrated that caffeine enhances the 
biotransformation of APAP mostly due to an effect of 
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FIGURE 4 – Pleiotropic effects of caffeine treatment after 24 h of TCPOBOP administration. (A, B and C) Representative images 
and quantification of immunohistochemistry for PCNA after 24 h of TCPOBOP administration between CT and CAF groups. The 
control samples in this analysis were from animals treated with water and TCPOBOP. (D, E and F) Representative images and 
quantification of Gap Junctional Intercellular Communication assay after 24 h of TCPOBOP administration between CT and CAF 
groups. The control samples in this analysis were from animals treated with water and TCPOBOP. (G and H) Expression of Nr1i3 
and Cyp2b10 mRNA. * means P<0.05 between CT and CAF groups. Black arrows indicate PCNA positive nuclei. White lines 
indicated the Lucifer yellow dye transfer.
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caffeine on the substrate-enzyme complex rather than 
an increase in the direct effect of caffeine on APAP 
binding to cytochrome p450 (Jaw, Jeffery, 1993). In 
addition, some reports have already demonstrated that 
prior treatment with caffeine altered APAP metabolism 
and hence increased its hepatotoxicity in rodents 
(Sato, Izumi, 1989; Jaw, Jeffery, 1993). When caffeine 
is used as a pretreatment, it induces the microsomal 
mixed function oxidase system, leading to a more rapid 
rate of formation of the hepatotoxic arylating APAP 
biotransformation product (Gale et al., 1986). Therefore, 
shedding light on the possible modulation of liver 
p450 enzymes by caffeine through xenobiotic nuclear 
receptors is important.
Although we used a dose of caffeine (50 mg/kg) 
which could be considered elevated in this experiment, 
mice did not present any toxic effects since no changes 
in body or liver weight, serum ALT or histopathology 
of liver and other major organs were noted.  T h e s e 
results are in agreement with a study conducted by the 
National Toxicology Program (National-Toxicology-
Program, 1984) in which caffeine administration to 
female mice (CD-1 background) showed no effects 
in body or organ weight even in a high dose such as 
 93 mg/kg. One alteration noted in our first experiment 
was the increased gene expression of Nr1i3 and its 
transcriptional target Cyp2b10, which led us to perform 
the second experiment where we evaluated the effects of 
caffeine on TCPOBOP-treated mice.
We previously showed that TCPOBOP under 
the same protocol used here induced hepatomegaly, 
hepatotoxicity and loss of cell-to-cell communication 
through Gap Junctions (Fukumasu et al., 2010). The 
most prominent effect of TCPOBOP on mice liver was 
hepatomegaly, as the liver doubled its weight after 72 
h due mostly to increased hepatocyte proliferation over 
hypertrophy. In addition, this effect in cell proliferation 
could be responsible, in part, for the alterations in gap 
junction intercellular communication since an inverse 
association between these two cell processes is well known 
(Yamasaki et al., 1999).
This mitogenic effect of TCPOBOP in liver cells 
was recently shown to be a possible alternative for the 
rescue of regenerative response in cirrhotic livers (Bugyik 
et al., 2012). However, attention should be given before 
using Nr1i3 ligands for any therapeutic purposes since 
we showed here that caffeine, a substance consumed 
worldwide, potentiated some effects of the Nr1i3 ligand in 
mice. It could be possible that other commonly consumed 
substances could modify Nr1i3 ligand effects. In fact, 
substances present in garlic (Sueyoshi et al., 2011) and 
Yin zhi huang, a traditional Chinese herbal extract with 
Artemisia capilaris) (Huang et al., 2004), have been 
shown as activators of Nr1i3.
CONCLUSION
To the best of our knowledge, this is the first 
demonstration that caffeine increases Nr1i3 gene 
expression and potentiated TCPOBOP, the most potent 
known Nr1i3 ligand in mice. Future studies should be 
performed to determine if these effects of caffeine directly 
or indirectly modulate Nr1i3.
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